{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:11:48Z","timestamp":1790802708854,"version":"4.1.0"},"reference-count":23,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"unspecified","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013964","name":"Department of Zoology, University of Oxford","doi-asserted-by":"crossref","award":["Lectureship in Infectious Diseases"],"award-info":[{"award-number":["Lectureship in Infectious Diseases"]}],"id":[{"id":"10.13039\/100013964","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Wellcome intermediate fellowship","award":["110110\/Z\/15\/Z"],"award-info":[{"award-number":["110110\/Z\/15\/Z"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2020,12,9]]},"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:p>The COVID-19 pandemic caused by the SARS-CoV-2 virus has resulted in a myriad of interventions with the urgent aim of reducing the public health impact of this virus. However, a wealth of evidence both from high-income and low-income countries is accruing on the broader consequences of such interventions on economic and public health inequalities, as well as on pre-existing programmes targeting endemic pathogens. We provide an overview of the impact of the ongoing COVID-19 pandemic on hepatitis B virus (HBV) programmes globally, focusing on the possible consequences for prevention, diagnosis and treatment. Ongoing disruptions to infrastructure, supply chains, services and interventions for HBV are likely to contribute disproportionately to the short-term incidence of chronic hepatitis B, providing a long-term source of onward transmission to future generations that threatens progress towards the 2030 elimination goals.<\/jats:p>","DOI":"10.1136\/bmjgh-2020-004275","type":"journal-article","created":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T12:25:17Z","timestamp":1609849517000},"page":"e004275","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":69,"title":["The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection"],"prefix":"10.1136","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2611-1262","authenticated-orcid":false,"given":"Caitlin M","family":"Pley","sequence":"first","affiliation":[{"name":"School of Clinical Medicine, University of Cambridge School of Clinical Medicine, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L","family":"McNaughton","sequence":"additional","affiliation":[{"name":"Nuffield Department of Medicine, Medawar Building for Pathogen Research, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippa C","family":"Matthews","sequence":"additional","affiliation":[{"name":"Nuffield Department of Medicine, Medawar Building for Pathogen Research, University of Oxford, Oxford, UK"},{"name":"Department of Microbiology and Infectious Diseases, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9318-2581","authenticated-orcid":false,"given":"Jos\u00e9","family":"Louren\u00e7o","sequence":"additional","affiliation":[{"name":"Department of Zoology, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,1,5]]},"reference":[{"key":"2025073014180895000_6.1.e004275.1","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13423","article-title":"Global perspective of COVID\u201019 epidemiology for a full\u2010cycle pandemic","volume":"50","author":"Ioannidis","year":"2020","journal-title":"Eur J Clin Invest"},{"key":"2025073014180895000_6.1.e004275.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30204-3"},{"key":"2025073014180895000_6.1.e004275.3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S2468-1253(18)30270-X","article-title":"Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission","volume":"4","author":"Cooke","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025073014180895000_6.1.e004275.4","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S2468-1253(20)30305-8","article-title":"Effect of the COVID-19 pandemic on viral hepatitis services in sub-Saharan Africa","volume":"5","author":"Lemoine","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025073014180895000_6.1.e004275.5","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S2468-1253(18)30056-6","article-title":"Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study","volume":"3","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025073014180895000_6.1.e004275.6","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S2468-1253(20)30238-7","article-title":"The impact of COVID-19 on hepatitis elimination","volume":"5","author":"Wingrove","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025073014180895000_6.1.e004275.7","doi-asserted-by":"crossref","unstructured":"Masresha BG , Luce R , Weldegebriel G , et al . The impact of a prolonged Ebola outbreak on measles elimination activities in guinea, Liberia and Sierra Leone, 2014-2015. Pan Afr Med J 2020;35.doi:10.11604\/pamj.supp.2020.35.1.19059","DOI":"10.11604\/pamj.supp.2020.35.1.19059"},{"key":"2025073014180895000_6.1.e004275.8","unstructured":"Gates B , Gates M . 2020 Goalkeepers Report. COVID-19 A Global Perspective. [Internet], 2020. Available: https:\/\/www.gatesfoundation.org\/goalkeepers\/report\/2020-report\/#GlobalPerspective [Accessed 01 Oct 2020]."},{"key":"2025073014180895000_6.1.e004275.9","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6919e2"},{"key":"2025073014180895000_6.1.e004275.10","doi-asserted-by":"crossref","first-page":"2000848","DOI":"10.2807\/1560-7917.ES.2020.25.19.2000848","article-title":"Early impact of the coronavirus disease (COVID-19) pandemic and physical distancing measures on routine childhood vaccinations in England, January to April 2020","volume":"25","author":"McDonald","year":"2020","journal-title":"Eurosurveillance"},{"key":"2025073014180895000_6.1.e004275.11","doi-asserted-by":"crossref","first-page":"e1264","DOI":"10.1016\/S2214-109X(20)30308-9","article-title":"Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infection","volume":"8","author":"Abbas","year":"2020","journal-title":"Lancet Glob Health"},{"key":"2025073014180895000_6.1.e004275.12","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S2468-1253(20)30155-2","article-title":"Converging pandemics: implications of COVID-19 for the viral hepatitis response in sub-Saharan Africa","volume":"5","author":"Gupta","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025073014180895000_6.1.e004275.13","doi-asserted-by":"crossref","first-page":"e02016","DOI":"10.1016\/j.heliyon.2019.e02016","article-title":"Vaccination hesitancy: fear, trust, and exposure expectancy of an Ebola outbreak","volume":"5","author":"Mesch","year":"2019","journal-title":"Heliyon"},{"key":"2025073014180895000_6.1.e004275.14","doi-asserted-by":"crossref","DOI":"10.7196\/SAMJ.2020.v110i6.14832","article-title":"COVID-19 restrictions and increased risk of overdose for street-based people with opioid dependence in South Africa","volume":"110","author":"Stowe","year":"2020","journal-title":"S Afr Med J"},{"key":"2025073014180895000_6.1.e004275.15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/cld.970","article-title":"SARS-CoV-2 and the liver: considerations in hepatitis B and hepatitis C infections","volume":"15","author":"Reddy","year":"2020","journal-title":"Clin Liver Dis"},{"key":"2025073014180895000_6.1.e004275.16","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.dld.2020.07.008","article-title":"Assessing the impact of COVID-19 on the management of patients with liver diseases: a national survey by the Italian association for the study of the liver","volume":"52","author":"Aghemo","year":"2020","journal-title":"Dig Liver Dis"},{"key":"2025073014180895000_6.1.e004275.17","doi-asserted-by":"crossref","unstructured":"Toyoda H , Huang DQ , MH L . Liver care and surveillance: the global impact of the COVID-19 pandemic. Hepatol Commun 2020.","DOI":"10.1002\/hep4.1579"},{"key":"2025073014180895000_6.1.e004275.18","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jhep.2020.06.001","article-title":"High rates of 30-day mortality in patients with cirrhosis and COVID-19","volume":"73","author":"Iavarone","year":"2020","journal-title":"J Hepatol"},{"key":"2025073014180895000_6.1.e004275.19","article-title":"Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study","author":"Marjot","year":"2020","journal-title":"J Hepatol"},{"key":"2025073014180895000_6.1.e004275.20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/jvh.13410","article-title":"Low risk of hepatitis B reactivation in patients with severe COVID-19 who receive immunosuppressive therapy","volume":"28","author":"Rodr\u00edguez-Tajes","year":"2021","journal-title":"J Viral Hepat"},{"key":"2025073014180895000_6.1.e004275.21","doi-asserted-by":"crossref","unstructured":"World Bank . Poverty and shared prosperity 2020: reversals of fortune. Washington, DC: world bank. 10.1596\/978-1-4648-1602-4. license: creative commons attribution CC by 3.0 IGO, 2020.","DOI":"10.1596\/978-1-4648-1602-4"},{"key":"2025073014180895000_6.1.e004275.22","unstructured":"Bivens J , Zipperer B . Health insurance and the COVID-19 shock: what we know so far about health insurance losses and what it means for policy [Internet]. Economic Policy Institute 2020 https:\/\/www.epi.org\/publication\/health-insurance-and-the-covid-19-shock\/"},{"key":"2025073014180895000_6.1.e004275.23","unstructured":"World Health Organization . Pulse survey on continuity of essential health services during the COVID-19 pandemic: interim report, 2020. Available: https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-EHS_continuity-survey-2020.1 [Accessed 2 Dec 2020]."}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2020-004275","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T21:18:19Z","timestamp":1753910299000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2020-004275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1,5]]},"published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1136\/bmjgh-2020-004275"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2020-004275","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}